A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Donepezil Hydrochloride (E2020) in Patients With Dementia Associated With Cerebrovascular Disease
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 05 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Sep 2018.
- 05 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.
- 05 Feb 2018 Status changed from recruiting to active, no longer recruiting.